BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24357159)

  • 1. Clinicopathological features and prognosis of pregnancy associated breast cancer - a matched case control study.
    Madaras L; Kovács KA; Szász AM; Kenessey I; Tőkés AM; Székely B; Baranyák Z; Kiss O; Dank M; Kulka J
    Pathol Oncol Res; 2014 Jul; 20(3):581-90. PubMed ID: 24357159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: A case-control study of 87 cases.
    Genin AS; De Rycke Y; Stevens D; Donnadieu A; Langer A; Rouzier R; Lerebours F
    Breast; 2016 Dec; 30():222-227. PubMed ID: 26456897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype.
    Bae SY; Jung SP; Jung ES; Park SM; Lee SK; Yu JH; Lee JE; Kim SW; Nam SJ
    Oncology; 2018; 95(3):163-169. PubMed ID: 29913459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.
    Song Y; Liu X; Zhang G; Song H; Ren Y; He X; Wang Y; Zhang J; Zhang Y; Sun S; Liang X; Sun Q; Pang D
    World J Surg Oncol; 2013 Jun; 11():129. PubMed ID: 23738706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and survival of pregnancy-associated breast cancer: a retrospective study of 203 cases in China.
    Han BY; Li XG; Zhao HY; Hu X; Ling H
    BMC Cancer; 2020 Mar; 20(1):244. PubMed ID: 32293328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.
    Curigliano G; Disalvatore D; Esposito A; Pruneri G; Lazzeroni M; Guerrieri-Gonzaga A; Luini A; Orecchia R; Goldhirsch A; Rotmensz N; Bonanni B; Viale G
    Ann Oncol; 2015 Apr; 26(4):682-687. PubMed ID: 25600567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.
    Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A
    Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer.
    Michieletto S; Saibene T; Evangelista L; Barbazza F; Grigoletto R; Rossi G; Ghiotto C; Bozza F
    Breast; 2014 Feb; 23(1):19-25. PubMed ID: 24189101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer.
    Fan Y; Ding X; Xu B; Ma F; Yuan P; Wang J; Zhang P; Li Q; Luo Y
    Medicine (Baltimore); 2015 Nov; 94(46):e2066. PubMed ID: 26579819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall survival is improved when DCIS accompanies invasive breast cancer.
    Kole AJ; Park HS; Johnson SB; Kelly JR; Moran MS; Patel AA
    Sci Rep; 2019 Jul; 9(1):9934. PubMed ID: 31289308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study.
    Halaska MJ; Pentheroudakis G; Strnad P; Stankusova H; Chod J; Robova H; Petruzelka L; Rob L; Pavlidis N
    Breast J; 2009; 15(5):461-7. PubMed ID: 19624421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical subtypes and prognosis of pregnancy-associated breast cancer: results from the Korean Breast Cancer Society Registry database.
    Bae SY; Kim SJ; Lee J; Lee ES; Kim EK; Park HY; Suh YJ; Kim HK; You JY; Jung SP
    Breast Cancer Res Treat; 2018 Nov; 172(1):113-121. PubMed ID: 30088177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period.
    O'Sullivan CC; Irshad S; Wang Z; Tang Z; Umbricht C; Rosner GL; Christianson MS; Stearns V; Smith KL
    Breast Cancer Res Treat; 2020 Apr; 180(3):695-706. PubMed ID: 32162192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer.
    Murphy CG; Mallam D; Stein S; Patil S; Howard J; Sklarin N; Hudis CA; Gemignani ML; Seidman AD
    Cancer; 2012 Jul; 118(13):3254-9. PubMed ID: 22086863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Om.breast cancer in very young women aged 25 year-old or below in the center of Tunisia and review of the literature.
    Ben Abdelkrim S; Fathallah K; Rouatbi R; Ayachi M; Hmissa S; Mokni M
    Pathol Oncol Res; 2015 Jul; 21(3):553-61. PubMed ID: 25962349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
    Ding S; Wu J; Lin C; Chen W; Li Y; Shen K; Zhu L
    Clin Breast Cancer; 2019 Feb; 19(1):e66-e73. PubMed ID: 30396812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
    Amirifard N; Sadeghi E
    Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era.
    Nye L; Rademaker A; Gradishar WJ
    Clin Breast Cancer; 2017 Jul; 17(4):e185-e189. PubMed ID: 28185739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study.
    Morgan E; Suresh A; Ganju A; Stover DG; Wesolowski R; Sardesai S; Noonan A; Reinbolt R; VanDeusen J; Williams N; Cherian MA; Li Z; Young G; Palettas M; Stephens J; Liu J; Luff A; Ramaswamy B; Lustberg M
    World J Surg Oncol; 2020 Jan; 18(1):11. PubMed ID: 31937323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.